Selenium-Based Antihypertensives
- 1 January 1998
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 56 (6) , 959-964
- https://doi.org/10.2165/00003495-199856060-00001
Abstract
Selenium, long recognised as an important ‘dietary antioxidant’, is now known to be an essential component of the active sites of a number of enzymes, including the glutathione peroxidase...Keywords
This publication has 24 references indexed in Scilit:
- The enantiomeric specificity of the antihypertensive activity of 1-(phenylthio)-2-aminopropane, a synthetic substrate analog for dopamine .beta.-monooxygenaseJournal of Medicinal Chemistry, 1991
- The pharmacology and mechanisms of action of histamine H1‐antagonistsClinical and Experimental Allergy, 1990
- Clinical Use of ??-Andrenoceptor Blockade in Systemic HypertensionDrugs, 1990
- Novel antihypertensives targeted at dopamine .beta.-monooxygenase: turnover-dependent cofactor depletion by phenylaminoethylselenideJournal of Medicinal Chemistry, 1988
- Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditionsBiochemical Pharmacology, 1987
- The role of selenium peroxidases in the protection against oxidative damage of membranesChemistry and Physics of Lipids, 1987
- Ascorbate depletion as a consequence of product recycling during dopamine .beta.-monooxygenase catalyzed selenoxidationBiochemistry, 1987
- Substituted 1-benzylimidazole-2-thiols as potent and orally active inhibitors of dopamine .beta.-hydroxylaseJournal of Medicinal Chemistry, 1986
- CAN SELENOAMINO ACIDS ACT AS REVERSIBLE BIOLOGICAL ANTIOXIDANTS*Annals of the New York Academy of Sciences, 1972
- Selenomethionine as an AntioxidantNature, 1961